Only two medications are FDA-approved specifically for PTSD: sertraline and paroxetine, both of which belong to a class of antidepressants called SSRIs. In practice, though, doctors prescribe a wider range of medications depending on which symptoms are most disruptive. Here’s what those options look like and what to expect from them.
First-Line Medications: SSRIs
SSRIs work by increasing the availability of serotonin in the brain, a chemical messenger involved in mood regulation, anxiety, and sleep. For PTSD specifically, this helps reduce the intensity of intrusive memories, emotional numbness, and the constant state of being on edge that characterizes the disorder. Sertraline and paroxetine are the two with formal FDA approval, but doctors also commonly prescribe fluoxetine for PTSD based on clinical evidence.
Common side effects include upset stomach, sweating, headache, dizziness, and sexual side effects like reduced desire or difficulty reaching orgasm. Some of these fade within the first few weeks, while others, particularly the sexual side effects, can persist for as long as you take the medication. Most people tolerate SSRIs well enough to stay on them, but if one SSRI causes problems, switching to another often helps since individuals respond differently to each one.
SNRIs and Other Off-Label Options
When SSRIs don’t provide enough relief, venlafaxine is one of the most common next steps. It’s an SNRI, meaning it increases both serotonin and norepinephrine, another brain chemical tied to alertness and stress response. By affecting norepinephrine pathways, SNRIs can also influence dopamine signaling in the front part of the brain, which plays a role in emotional regulation and decision-making. Venlafaxine has solid evidence behind it for PTSD, even though it lacks formal FDA approval for that use.
Mirtazapine is another off-label option, sometimes chosen because it has sedating and anti-nausea properties that can help people whose PTSD involves severe insomnia or appetite loss. It works through a different mechanism than SSRIs or SNRIs, targeting multiple receptor systems at once.
Prazosin for PTSD Nightmares
Nightmares are one of the most treatment-resistant symptoms of PTSD, and standard antidepressants often don’t fully address them. Prazosin, originally a blood pressure medication, has become widely used for this purpose. It blocks a specific type of adrenaline receptor in the brain, which appears to reduce the intensity and frequency of trauma-related nightmares and improve overall sleep quality.
Dosing typically starts at 1 mg at bedtime and is gradually increased week by week. Effective doses vary widely: elderly patients may respond to around 2 to 3 mg, while combat veterans in clinical studies sometimes needed 10 to 15 mg. In one study of 59 veterans, 78% showed improvement in nightmare severity. The most common side effects are dizziness, light-headedness, and occasional drops in blood pressure when standing up, all of which tend to be manageable at lower doses. When people stop taking prazosin, nightmares typically return, suggesting it controls symptoms rather than resolving them permanently.
Augmentation for Treatment-Resistant PTSD
Some people take an SSRI at an adequate dose for a reasonable period and still don’t get enough symptom relief. In these cases, doctors may add a second medication rather than replacing the first. A recent trial of 416 adults with PTSD found that adding brexpiprazole (an atypical antipsychotic) to sertraline produced significantly greater improvement in PTSD symptoms over 10 weeks compared to sertraline alone. This augmentation approach is still relatively new for PTSD, but it reflects a broader pattern in psychiatry where combining medications with different mechanisms can address symptoms that a single drug misses.
Why Benzodiazepines Are Not Recommended
Despite their reputation as anti-anxiety drugs, benzodiazepines are strongly recommended against for PTSD. The 2023 VA/DoD Clinical Practice Guideline made this position clear, based on a consistent lack of evidence that they actually work for PTSD symptoms. A systematic review of placebo-controlled trials found no benefit, and a meta-analysis of over 5,200 participants across 18 studies concluded that the risks outweigh any short-term relief.
The problems go beyond ineffectiveness. Benzodiazepines can interfere with the trauma-processing therapies that are most effective for PTSD, essentially blunting the emotional engagement needed for those treatments to work. They carry significant risks of dependence, which is especially concerning given that PTSD frequently co-occurs with substance use disorders. In veterans specifically, benzodiazepines have been linked to increased aggression in people who were already prone to it, and their cognitive effects are particularly harmful in older adults. They also worsen sleep apnea and chronic lung conditions, both of which are common in people with PTSD.
Medication Combined With Therapy
Medication is rarely the whole answer for PTSD. A large network meta-analysis published in JAMA Psychiatry compared medication alone, psychotherapy alone, and the combination. At long-term follow-up, psychotherapy outperformed medication on its own, and combined treatment was associated with better outcomes than medication alone. Interestingly, combining medication with therapy did not clearly outperform therapy by itself, suggesting that trauma-focused psychotherapy is the more powerful ingredient in the long run.
That said, medication plays a critical practical role. It can reduce symptoms enough for someone to engage meaningfully in therapy, particularly when hyperarousal, insomnia, or severe anxiety makes it hard to sit through sessions or do the between-session work that therapy requires. Most treatment courses involve 12 to 16 weekly therapy sessions for initial improvement, with about 50% of patients recovering within 15 to 20 sessions. People with co-occurring conditions like depression or substance use may need 12 to 18 months of treatment.
What Improvement Looks Like
SSRIs and SNRIs generally take 4 to 6 weeks before you notice meaningful changes, and full effects can take 8 to 12 weeks. This is a common point of frustration, but it reflects how long it takes for these medications to shift the brain’s chemical signaling patterns. Your prescriber will likely check in at regular intervals and may adjust the dose during this window. If one medication hasn’t helped after an adequate trial at a therapeutic dose, switching to a different one or adding an augmentation strategy is a reasonable next step, not a sign that medication won’t work for you at all.